Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abortion, spontaneous
ACTH
acute disseminated encephalomyelitis
advances in neurology
adverse drug reaction
aerobic exercise
alemtuzumab
algorithm
alkylating agents
alopecia
alternative medicine
amantadine
amenorrhea
aminopyridine, 4
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, treatment of
anaphylaxis
anemia
anesthesia, epidural
anesthesia, spinal
anti JC virus antibodies
antihistamines
antineutrophil cytoplasmic autoantibodies
antisense therapy
antispasticity drugs
anxiety
arachnoiditis
arrhythmia, cardiac
asymptomatic
atorvastatin
audiogram
auditory and vestibular pathways
autoimmune disease
axonal degeneration
azathioprine
B cell lymphocyte depletion
B cell lymphocytes
baclofen
bacterial infection
bacterial infection, CNS
Barkhof MR criteria for MS
BENEFIT study
biologic markers
black box warning
bladder dysfunction
blood brain barrier
bone marrow suppression
bone marrow transplantation
botulinum toxin
bradycardia
bradykinesia
brain atrophy
brain biopsy
brain biopsy, false negative
brain biopsy, indication
brain biopsy, negative
brain volume
breast feeding
BTK inhibitors
candida albicans
carbamazepine
carcinoma
carcinoma of breast
cardiomyopathy
cardiotoxicity
CAT scan, chest
central nervous system, infection of
cerebral cortical atrophy
cerebral hypersensitivity, delayed
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, elevated protein of
cerebrovascular accident, secondary prevention
chemotherapy, CNS treatment and complications with
children
chills
cholecystitis
cladribine
clemastine fumarate
Clinical Pathologic Conference(C.P.C.)
clonus
cognition
coinfection
complementary medicine
compliance
complications
conduction block
confusion
congestive heart failure
contrast sensitivity
controversies in neurology
cooling therapy
cop 1
cost
cost effectiveness
cotton-wool spots
cranial neuropathy
cranial neuropathy, multiple
cryptococcal meningitis
cyclophosphamide
cyclosporine
cytokines
cytomegalovirus infection
daclizumab
dantrolene sodium
degenerative diseases of CNS
delay in diagnosis
demyelinating disease
depression
dermatomyositis
dexamethasone suppression test
diagnostic criteria
diaminopyridine, 3, 4
diet
dietary supplement
differential diagnosis
digitalis
dilantin
disability rating scale, neurological
disability, neurological
disease modifying agents
dizziness
dorsal column stimulator
droperidol
drowsiness
drug holiday
drug induced neurologic disorders
drug interactions
drug withdrawal
dura, thickened
dysgeusia
echocardiogram
efficacy
ejection fraction
ejection fraction, abnormal
electrocardiogram, abnormal
emotional lability
empyema, epidural
encephalitis, viral
eosinophilia
epidemiology of neurology
epidural steroid
Epstein-Barr virus
Epstein-Barr virus, negative
ethics in neurology
EVIDENCE trial
evidence-based research
evoked potentials
exercise
exercise-induced vascular symptoms
facial weakness
fasciculation
fatigue
fetus
fever
fingolimod
fingolimod, discontinuation
flexor spasm
flicker fusion test
flu-like illness
frexalimab
fumarate
fundus, abnormality of
gadolinium
gag reflex, depressed
gait disorder
gamma amino butyric acid-mimetic drug
gammaglobulin therapy, intravenous
genetic neurologic disorders
granulomatosis with polyangiitis
grasp reflex
gray matter
guanidine
Guillain Barre syndrome
headache
hearing loss
hemophagocytic lymphohistiocytosis
hepatic failure
herniated disc, steroid treatment of
herpes simplex encephalitis
herpes simplex virus
herpes virus
herpes virus infection
herpes zoster
herpes zoster, disseminated
herpes zoster, ophthalmicus
HLA
hot bath test
human herpesvirus 6
hydrocephalus
hydrocephalus, exvacuo
hyperbaric oxygen
hyperbaric treatment
hyperhidrosis
hypersensitivity reaction
hypertension
hyperthermia
hypothermia
iatrogenic neurologic disorders
ibuprofen
idiopathic thrombocytopenic purpura
immune reconstitution inflammatory syndrome
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
in situ hybridization
inclusion body myositis
infection
infliximab
infusion pump
infusion-associated reaction
interferon
interferon alpha
interferon antibodies
interferon beta 1-a
interferon beta 1-b
interferon gamma
interferon, intrathecal
interleukin 2
interleukin 6
internet
interobserver agreement
intrathecal antispasticity drugs
intrathecal steroid
intrauterine
intravenous
iron, serum, elevated
Isaacs syndrome
isoniazid
JC virus
laquinimod
leukemia
leukopenia
limbic encephalitis
linomide
listeria monocytogenes
liver disease
liver function enzymes
lymphadenopathy
lymphoma
lymphoma, primary of CNS
lymphopenia
macular edema
mannitol
marihuana
McDonald criteria for MS
meclizine
medication withdrawal
melanoma, malignant
memory, impairment of
meningeal biopsy
meningeal enhancement
meningitis
meningitis, aseptic
meningitis, bacterial
meningitis, granulomatous
meningitis, TB
menses
menses, irregular
metallic taste
methotrexate
mimics
misdiagnosis
mitoxantrone
modafinil
monoclonal antibodies
mortality
motor neuron disease
MRI
MRI, abnormal
MRI, black holes on
MRI, contrast enhanced
MRI, demyelinating disease
MRI, false negative
MRI, field strength, high
MRI, hypointense signal foci on
MRI, lesion burden
MRI, magnetization transfer sequence
MRI, negative
MRI, optic nerve
MRI, ring sign, open
MRI, serial
MRI, volumetry
MRS
multinucleated giant cell
multiple sclerosis
multiple sclerosis, acute
multiple sclerosis, aggressive
multiple sclerosis, asymptomatic
multiple sclerosis, benign form of
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, conversion to clinically definite
multiple sclerosis, cost of
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, diet in
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, disease activity
multiple sclerosis, early onset
multiple sclerosis, epidemiology of
multiple sclerosis, etiology of
multiple sclerosis, lesion location
multiple sclerosis, linoleic acid in
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, pain in
multiple sclerosis, paroxysmal symptoms in
multiple sclerosis, pathogenesis
multiple sclerosis, plaque
multiple sclerosis, preclinical
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
multiple sclerosis, tumefactive
multiple sclerosis, worsening
muscle atrophy, static
muscle pain
muscle stiffness
muscle weakness
myasthenia gravis
myasthenia gravis, drug induced
myasthenia gravis, treatment of
myasthenic syndrome
myasthenic syndrome, treatment of
mycophenolate
myelin basic protein
myocardial injury
myocytolysis
myokymia
N-acetyl-L-aspartic acid
natalizumab
natalizumab, discontinuation
nausea and vomiting
negative
neurofilament light chain protein
neurogenic bladder
neurologic complications
neurologic complications of, surgery
neurologic disease
neurologic disease, diagnoses of
neurologic examination
neurologic practice
neurologic signs
neurologic symptoms
neurologist
neuromyelitis optica (Devic's disease)
neuromyotonia
neuropathology
neuropathology, brain
neuropathy
neuropathy, iatrogenic
neuropathy, immune
neuropathy, medication induced
neuropathy, motor, multifocal
neuropathy, multifocal
neuropathy, peripheral
neuropathy, peripheral, treatment
neuroprotective agents
neurosyphilis
neurotoxic
neurotoxin
neutralizing antibodies
neutropenia
nevus
nocardiosis
nocturia
nonsteroidal anti-inflammatory drug
ocrelizumab
ofatumumab
opportunistic infection
opportunistic infection, CNS
optic neuritis
optic neuritis, treatment of
optical coherence tomography
organ transplantation
outcome research
oxybutynin
pachymeningitis, cranial
pain
pain, abdominal
pancreatitis
pancytopenia
paraparesis, spastic
paresthesias
Parkinson disease
Parkinson disease, L-dopa nonresponsive
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
paroxysmal neurologic deficits
patient information and support
pemoline
pentoxifylline
pericarditis
personality change
placebo
plasmapheresis
pleocytosis of cerebrospinal fluid
pleurisy
polymerase chain reaction
polymerase chain reaction, false negative
polymyositis
polyneuropathy, chronic inflammatory demyelinating
posterior leukoencephalopathy syndrome
postpartum
practice guidelines
precipitating factors
pregnancy, neurologic complications in
prevention of neurologic disorders
primrose oil
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
psychological testing
quality of life
radiation therapy, CNS treatment and complications with
radiation therapy, total body
radiculopathy
Ramsay Hunt syndrome
rash
rebound
ReBUILD study
recurrent
remyelination
renal failure
research
retinopathy
reversible neurologic disorder
review article
risk factors
risk stratification
risk-benefit assessment
rituximab
safety
sedimentation rate, elevated
seizure
serologic testing
seropositive
serum alanine aminotransferase
serum glutamic oxaloacetic transaminase
shared decision making
simvastatin
sinemet
skin, lesions in neurologic disorders
spasticity
spasticity, treatment of
spinal cord, injury of
spinal cord, injury, management of
statin therapy
stem cell transplantation
stereotaxic surgery
steroid
steroid therapy, CNS treatment and complications with
stiff man syndrome
stimulation, deep brain
subspecialist
sweating
sweating, abnormality of
syphilis, neurologic complications with
T cell lymphocytes
tentorium cerebelli
teriflunomide
thalamotomy
thrombocytopenia
tizanidine
tolebrutinib
tolerance
treatment of neurologic disorder
tremor
tremor, cerebellar
tremor, surgical treatment of
tremor, thalamic stimulation for suppression of
tremor, treatment of
tricyclic antidepressant
tuberculin skin test, positive
tumor necrosis factor
tumor necrosis factor inhibitor
urinary retention
urinary tract infection
urodynamics
vaccination, neurologic complications with
vaccine
valium
vasopressin
ventricular enlargement
vertigo
vertigo, cervical
vertigo, treatment of
viral infection
viral infection, CNS
viral infection, reactivation
visual acuity
visual acuity, decreased
visual evoked response
visual loss
vitamin D
vitamin supplementation
vitamin, multiple
weakness
web sites
white matter disease
workup
yoga
Showing articles 300 to 350 of 4024 << Previous Next >>

Plasmapheresis in Acute Episodes of Fulminant CNS Inflammatory Demyelination
Neurol 43:1100-1104, Rodriquez,M.,et al, 1993

Long-Term Safety of Azathioprine Therapy in Multiple Sclerosis
Neurol 43:831-833, Amato,M.P.,et al, 1993

Intermittent Cyclophosphamide Pulse Therapy in Progressive MS:NE Coop MS Trtm Grp
Neurol 43:910-918, Weiner,H.L.,et al, 1993

Interferon Beta-1b is Effective in Relapsing-Remitting MS
Clinical Results of a Placebo-Controlled Trial, IFNB MS Study Grp, Neurol 43:655-661, 64193., , 1993

Interferon Beta-1b is Effective in Relapsing Remitting MS, MRI Analysis Results of Placebo-Control Trial
Neurol 43:662-667, 6411993., Paty,D.W.,et al, 1993

Open Controlled Therapeutic Trial of Intravenous Immune Globulin in Relapsing-Remitting Multiple Sclerosis
Arch Neurol 49:1233-1236, Achiron,A.,et al, 1992

A Correlative Triad of Gadolinium-DTPA MRI, EDSS, & CSF-MBP in Relapsing MS Treated with High-Dose Intravenous Methylprednisolone
Neurol 42:63-67, Barkhof,F.,et al, 1992

DDAVP in the Management of Nocturia in Multiple Sclerosis
Ann Neurol 31:577, Valiquette,G.,et al, 1992

A Double-Blind, Renadomized, Crossover Trial of Pemoline in Fatigue Assoc with Multiple Sclerosis
Neurol 42:1468-1471, Weinshenker,B.G.,et al, 1992

The Effect of 4-Aminopyridine on Clinical Signs in Multiple Sclerosis
Ann Neurol 32:123-130, vanDiemen,H.A.M.,et al, 1992

Overview of Azathioprine Treatment in Multiple Sclerosis
Lancet 338:1051-1055, Yudkin,P.L.,et al, 1991

Intense Immunosuppression in Chronic Progressive Multiple Sclerosis:The Kaiser Study
JNNP 54:1055-1060, Likosky,W.H.,et al, 1991

Treatment of Multiple Sclerosis with Hyperbaric Oxygen
Arch Neurol 48:195-199, Kindwall,E.P.,et al, 1991

The Efficacy of Azathiorpine in Relapsing-Remitting Multiple Sclerosis
Neurol 41:20-25, Goodkin,D.E.,et al, 1991

The Canadian Coop Trial of Cyclophosphamide and Plasma Exchange in Progr MS
The Canadian Coop MS Study Group, Lancet 337:441-4461991., , 1991

Plasma Exchange in Chronic Progressive Multiple Sclerosis:A Long-Term Study
Neurol 41:409-414, Khatri,B.O.,et al, 1991

4-Aminopyridine in Multiple Sclerosis:Prolonged Administration
Neurol 41:1344-1348, Stefoski,D.,et al, 1991

A Placebo-Controlled, Double-Blind, Randomized, Two-Center, Pilot Trial of Cop 1 in Chronic Progressive MS
Neurol 41:533-539, Bornstein,M.B.,et al, 1991

The Use of Immunosuppressive Agents in the Treatment of Multiple Sclerosis:A Critical Review
Neurol 41:980-985, Goodin,D.S., 1991

Treatment of Spasticity with Botulinum Toxin:A Double-Blind Study
Ann Neurol 28:512-515, Snow,B.J.,et al, 1990

Effect of Digitalis on Clinical Symptoms and Conduction Variables in Patients with Multiple Sclerosis
Ann Neurol 28:582-584, Kaji,R.,et al, 1990

Efficacy & Toxicity of Cyclosporine in Chronic Progressive Multiple Sclerosis:A Randomized Clinical Trial
M. S. Study Group, Ann Neurol 27:591-605, 5890., , 1990

Orally Administered 4-Aminopyridine Improves Clinical Signs in Multiple Sclerosis
Ann Neurol 27:186-192, Davis,F.A.,et al, 1990

Preliminary Trial of 3, 4-Diaminopyridine in Patients with Multiple Sclerosis
Ann Neurol 27:421-427, Bever,C.T.,et al, 1990

Effect of Low Saturated Fat Diet in Early and Late Cases of Multiple Sclerosis
Lancet 336:37-39, 25-261990., Swank,R.L.&Dugan,B.B., 1990

Lipids and Multiple Sclerosis
Editorial, Lancet 336:25-261990., , 1990

Stereotaxic Thalamotomy-Experiences from the Levodopa Era
JNNP 53:427-430, Wester,K.&Hauglie-Hanssen,E., 1990

Amantadine Treatment of Fatigue Associated with Multiple Sclerosis
Arch Neurol 46:676-680, Cohen,R.A.&Fisher,M., 1989

Relative Efficacy of Intravenous Methylprednisolone and ACTH in the Treatment of Acute Relapse in MS
Neurol 39:969-971, Thompson,A.J.,et al, 1989

A Referendum on Clinical Trial Research in Multiple Sclerosis:Opinion of Jekyll Island Workshop
Neurol 39:977-981, Noseworthy,J.H.,et al, 1989

Double-Blind Study of True vs. Sham Plasma Exchange in Patients Treated with Immunosuppression for Acute Attacks of MS
Neurol 39:1143-1149, Weiner,H.L.,et al, 1989

Randomised Double Blind Controlled Trial of Cyclosporin in Multiple Sclerosis
JNNP 52:559-565, Rudge,P.,et al, 1989

A Placebo-Controlled, Randomized, Clinical Trial of Azathioprine with & without Methylpred in MS
Neurol 39:1018-1026, Ellison,G.W.,et al, 1989

Immunological Treatment for Multiple Sclerosis
Editorial, Lancet 1:699-7011989., , 1989

Treatment of Cerebellar Tremors with Carbamazepine:A Controlled Trial with Long-Term Follow-Up
Neurol 39:1113-1115, Sechi,G.P.,et al, 1989

Intrathecal Baclofen for Severe Spinal Spasticity
NEJM 320:1517-1521, 1553-15551989., Penn,R.D.,et al, 1989

Intrathecal Baclofen for Long-Term Treatment of Spasticity:A Multi-Centre Study
JNNP 52:933-939, Ochs,G.,et al, 1989

Consensus and Controversy in Neurologic Practice, The Case of Steroid Treatment in Multiple Sclerosis
Arch Neurol 46:322, Menken,M., 1989

Quantitative Magnetic Resonance Imaging in Multiple Sclerosis:The Effect of High Dose Intravenous Methylprednisolone
JNNP 52:14-17, Kesselring,J.,et al, 1989

Amantadine, Fatigue, and Multiple Sclerosis
Arch Neurol 45:1104-1106, Rosenberg,G.A.&Appenzeller,O., 1988

Methylprednisolone and Multiple Sclerosis
Arch Neurol 45:669-670, Compston,A., 1988

Double-Masked Trial of Azathioprine in Multiple Sclerosis
British and Dutch Multiple Sclerosis Azathioprine Trial Group, Lancet 2:179-1831988., , 1988

Dangers from Methylprednisolone Acetate Therapy by Intraspinal Injection
Arch Neurol 45:804-806, Nelson,D.A., 1988

Cyclosporine Vs. Azathioprine in the Long-Term Treatment of Multiple Sclerosi-Results of German Multicenter Study
Ann Neurol 23:56-63, Kappos,L.,et al, 1988

Immunotherapy of Multiple Sclerosis
Ann Neurol 23:211-223, Weiner,H.L.&Hafler,D.A., 1988

Controlled Pilot Trial of Monthly Intravenous Cyclophosphamide in Multiple Sclerosis
Arch Neurol 45:27-30, Killian,J.M.,et al, 1988

Cyclophosphamide"Pulses"in Chronic Progressive Multiple Sclerosis, A Preliminary Clinical Trial
Arch Neurol 44:828-832, Myers,L.W.,et al, 1987

Cyclophosphamide in Chronic Progressive Multiple Sclerosis, Maintenance vs Nonmaintenance Therapy
Arch Neurol 44:823-827, Goodkin,D.E.,et al, 1987

A Double-Blind Controlled Trial of High Dose Methylprednisolone in Patients with MS:1. Clinical Effects
JNNP 50:511-516, Milligan,M.N.,et al, 1987

Steroid Therapy in Multiple Sclerosis, Point of View
Arch Neurol 44:803-807, Troiano,R.,et al, 1987



Showing articles 300 to 350 of 4024 << Previous Next >>